Net profit of Jenburkt Pharmaceuticals declined 0.55% to Rs 5.40 crore in the quarter ended December 2023 as against Rs 5.43 crore during the previous quarter ended December 2022. Sales rose 3.15% to Rs 35.66 crore in the quarter ended December 2023 as against Rs 34.57 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales35.6634.57 3 OPM %20.1620.16 - PBDT8.478.33 2 PBT7.847.75 1 NP5.405.43 -1 Powered by Capital Market - Live News

Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 6 February 2024.Powered by Capital Market - Live News

Net profit of Jenburkt Pharmaceuticals rose 6.55% to Rs 7.32 crore in the quarter ended September 2023 as against Rs 6.87 crore during the previous quarter ended September 2022. Sales rose 6.81% to Rs 38.29 crore in the quarter ended September 2023 as against Rs 35.85 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales38.2935.85 7 OPM %23.7724.02 - PBDT10.139.78 4 PBT9.549.24 3 NP7.326.87 7 Powered by Capital Market - Live News

Net profit of Jenburkt Pharmaceuticals declined 9.75% to Rs 5.37 crore in the quarter ended June 2023 as against Rs 5.95 crore during the previous quarter ended June 2022. Sales declined 6.26% to Rs 29.18 crore in the quarter ended June 2023 as against Rs 31.13 crore during the previous quarter ended June 2022. ParticularsQuarter Ended�Jun. 2023Jun. 2022% Var. Sales29.1831.13 -6 OPM %23.8523.39 - PBDT7.938.33 -5 PBT7.437.79 -5 NP5.375.95 -10 Powered by Capital Market - Live News

Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 8 August 2023.Powered by Capital Market - Live News